 | • レポートコード：QY2108PAL8779 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおけるバイオシミラー医薬品の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、バイオシミラー医薬品の種類別市場規模（注射、錠剤、その他）、用途別市場規模（強直性脊椎炎、腫瘍、関節リウマチ、心臓血管、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界のバイオシミラー医薬品市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界におけるバイオシミラー医薬品の種類別市場規模（2016年-2027年）：注射、錠剤、その他 ・世界におけるバイオシミラー医薬品の用途別市場規模（2016年-2027年）：強直性脊椎炎、腫瘍、関節リウマチ、心臓血管、その他 ・バイオシミラー医薬品の中国市場分析 - バイオシミラー医薬品の中国市場規模（2016年-2027年） - 中国におけるバイオシミラー医薬品の主要プレイヤー別市場シェア - 中国におけるバイオシミラー医薬品の種類別市場規模：注射、錠剤、その他 - 中国におけるバイオシミラー医薬品の用途別市場規模：強直性脊椎炎、腫瘍、関節リウマチ、心臓血管、その他 ・バイオシミラー医薬品の北米市場（2016年-2027年） ・バイオシミラー医薬品のヨーロッパ市場（2016年-2027年） ・バイオシミラー医薬品のアジア太平洋市場（2016年-2027年） ・バイオシミラー医薬品の中南米市場（2016年-2027年） ・バイオシミラー医薬品の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：CP Guojian Pharma、Biotech Pharma、Celgen Pharma、Henlius、Amgen、Eli Lilly、Sandoz、Changchun High Tech、Innovent ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilar drug is officially approved versions of original “innovator” products, and can be manufactured when the original product’s patent expires.
In China, Biosimilar Drug key players include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, etc. Global top three manufacturers hold a share over 70%.
East China is the largest market, with a share over 70%, followed by North China, with a share about 15 percent.
In terms of product, Tablets is the largest segment, with a share over 65%. And in terms of application, the largest application is Ankylosing Spondylitis, followed by Rheumatoid Arthrtis, Tumor, Cardiovascular, etc.
Market Analysis and Insights: Global and China Biosimilar Drug Market
This report focuses on global and China Biosimilar Drug market.
In 2020, the global Biosimilar Drug market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Biosimilar Drug market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Biosimilar Drug Scope and Market Size
Biosimilar Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilar Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Biosimilar Drug market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Injection
Tablets
Other Types
Segment by Application
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius
Amgen
Eli Lilly
Sandoz
Changchun High Tech
Innovent
1 Study Coverage
1.1 Biosimilar Drug Product Introduction
1.2 Market by Type
1.2.1 Global Biosimilar Drug Market Size Growth Rate by Type
1.2.2 Injection
1.2.3 Tablets
1.2.4 Other Types
1.3 Market by Application
1.3.1 Global Biosimilar Drug Market Size Growth Rate by Application
1.3.2 Ankylosing Spondylitis
1.3.3 Tumor
1.3.4 Rheumatoid Arthrtis
1.3.5 Cardiovascular
1.3.6 Other Application
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biosimilar Drug Market Size, Estimates and Forecasts
2.1.1 Global Biosimilar Drug Revenue 2016-2027
2.1.2 Global Biosimilar Drug Sales 2016-2027
2.2 Global Biosimilar Drug, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Biosimilar Drug Historical Market Size by Region (2016-2021)
2.3.1 Global Biosimilar Drug Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Biosimilar Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Biosimilar Drug Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Biosimilar Drug Sales Forecast by Region (2022-2027)
2.4.2 Global Biosimilar Drug Revenue Forecast by Region (2022-2027)
3 Global Biosimilar Drug Competitor Landscape by Players
3.1 Global Top Biosimilar Drug Manufacturers by Sales
3.1.1 Global Biosimilar Drug Sales by Manufacturer (2016-2021)
3.1.2 Global Biosimilar Drug Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Biosimilar Drug Manufacturers by Revenue
3.2.1 Key Biosimilar Drug Manufacturers Covered: Ranking by Revenue
3.2.2 Global Biosimilar Drug Revenue by Manufacturers (2016-2021)
3.2.3 Global Biosimilar Drug Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Biosimilar Drug Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Biosimilar Drug Revenue in 2020
3.2.6 Global Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Biosimilar Drug Price by Manufacturers
3.4 Global Biosimilar Drug Manufacturing Base Distribution, Product Types
3.4.1 Biosimilar Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biosimilar Drug Product Type
3.4.3 Date of International Manufacturers Enter into Biosimilar Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Biosimilar Drug Market Size by Type (2016-2021)
4.1.1 Global Biosimilar Drug Sales by Type (2016-2021)
4.1.2 Global Biosimilar Drug Revenue by Type (2016-2021)
4.1.3 Biosimilar Drug Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Biosimilar Drug Market Size Forecast by Type (2022-2027)
4.2.1 Global Biosimilar Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Biosimilar Drug Revenue Forecast by Type (2022-2027)
4.2.3 Biosimilar Drug Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Biosimilar Drug Market Size by Application (2016-2021)
5.1.1 Global Biosimilar Drug Sales by Application (2016-2021)
5.1.2 Global Biosimilar Drug Revenue by Application (2016-2021)
5.1.3 Biosimilar Drug Price by Application (2016-2021)
5.2 Biosimilar Drug Market Size Forecast by Application (2022-2027)
5.2.1 Global Biosimilar Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Biosimilar Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Biosimilar Drug Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Biosimilar Drug Market Size YoY Growth 2016-2027
6.1.1 China Biosimilar Drug Sales YoY Growth 2016-2027
6.1.2 China Biosimilar Drug Revenue YoY Growth 2016-2027
6.1.3 China Biosimilar Drug Market Share in Global Market 2016-2027
6.2 China Biosimilar Drug Market Size by Players (International and Local Players)
6.2.1 China Top Biosimilar Drug Players by Sales (2016-2021)
6.2.2 China Top Biosimilar Drug Players by Revenue (2016-2021)
6.3 China Biosimilar Drug Historic Market Review by Type (2016-2021)
6.3.1 China Biosimilar Drug Sales Market Share by Type (2016-2021)
6.3.2 China Biosimilar Drug Revenue Market Share by Type (2016-2021)
6.3.3 China Biosimilar Drug Price by Type (2016-2021)
6.4 China Biosimilar Drug Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Biosimilar Drug Sales Forecast by Type (2022-2027)
6.4.2 China Biosimilar Drug Revenue Forecast by Type (2022-2027)
6.4.3 China Biosimilar Drug Price Forecast by Type (2022-2027)
6.5 China Biosimilar Drug Historic Market Review by Application (2016-2021)
6.5.1 China Biosimilar Drug Sales Market Share by Application (2016-2021)
6.5.2 China Biosimilar Drug Revenue Market Share by Application (2016-2021)
6.5.3 China Biosimilar Drug Price by Application (2016-2021)
6.6 China Biosimilar Drug Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Biosimilar Drug Sales Forecast by Application (2022-2027)
6.6.2 China Biosimilar Drug Revenue Forecast by Application (2022-2027)
6.6.3 China Biosimilar Drug Price Forecast by Application (2022-2027)
7 North America
7.1 North America Biosimilar Drug Market Size YoY Growth 2016-2027
7.2 North America Biosimilar Drug Market Facts & Figures by Country
7.2.1 North America Biosimilar Drug Sales by Country (2016-2021)
7.2.2 North America Biosimilar Drug Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Biosimilar Drug Market Size YoY Growth 2016-2027
8.2 Asia Pacific Biosimilar Drug Market Facts & Figures by Region
8.2.1 Asia Pacific Biosimilar Drug Sales by Region (2016-2021)
8.2.2 Asia Pacific Biosimilar Drug Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Biosimilar Drug Market Size YoY Growth 2016-2027
9.2 Europe Biosimilar Drug Market Facts & Figures by Country
9.2.1 Europe Biosimilar Drug Sales by Country (2016-2021)
9.2.2 Europe Biosimilar Drug Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Biosimilar Drug Market Size YoY Growth 2016-2027
10.2 Latin America Biosimilar Drug Market Facts & Figures by Country
10.2.1 Latin America Biosimilar Drug Sales by Country (2016-2021)
10.2.2 Latin America Biosimilar Drug Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Biosimilar Drug Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Biosimilar Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Biosimilar Drug Sales by Country (2016-2021)
11.2.2 Middle East and Africa Biosimilar Drug Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 CP Guojian Pharma
12.1.1 CP Guojian Pharma Corporation Information
12.1.2 CP Guojian Pharma Description and Business Overview
12.1.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CP Guojian Pharma Biosimilar Drug Products Offered
12.1.5 CP Guojian Pharma Recent Development
12.2 Biotech Pharma
12.2.1 Biotech Pharma Corporation Information
12.2.2 Biotech Pharma Description and Business Overview
12.2.3 Biotech Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Biotech Pharma Biosimilar Drug Products Offered
12.2.5 Biotech Pharma Recent Development
12.3 Celgen Pharma
12.3.1 Celgen Pharma Corporation Information
12.3.2 Celgen Pharma Description and Business Overview
12.3.3 Celgen Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Celgen Pharma Biosimilar Drug Products Offered
12.3.5 Celgen Pharma Recent Development
12.4 Henlius
12.4.1 Henlius Corporation Information
12.4.2 Henlius Description and Business Overview
12.4.3 Henlius Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Henlius Biosimilar Drug Products Offered
12.4.5 Henlius Recent Development
12.5 Amgen
12.5.1 Amgen Corporation Information
12.5.2 Amgen Description and Business Overview
12.5.3 Amgen Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Amgen Biosimilar Drug Products Offered
12.5.5 Amgen Recent Development
12.6 Eli Lilly
12.6.1 Eli Lilly Corporation Information
12.6.2 Eli Lilly Description and Business Overview
12.6.3 Eli Lilly Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Eli Lilly Biosimilar Drug Products Offered
12.6.5 Eli Lilly Recent Development
12.7 Sandoz
12.7.1 Sandoz Corporation Information
12.7.2 Sandoz Description and Business Overview
12.7.3 Sandoz Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sandoz Biosimilar Drug Products Offered
12.7.5 Sandoz Recent Development
12.8 Changchun High Tech
12.8.1 Changchun High Tech Corporation Information
12.8.2 Changchun High Tech Description and Business Overview
12.8.3 Changchun High Tech Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Changchun High Tech Biosimilar Drug Products Offered
12.8.5 Changchun High Tech Recent Development
12.9 Innovent
12.9.1 Innovent Corporation Information
12.9.2 Innovent Description and Business Overview
12.9.3 Innovent Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Innovent Biosimilar Drug Products Offered
12.9.5 Innovent Recent Development
12.11 CP Guojian Pharma
12.11.1 CP Guojian Pharma Corporation Information
12.11.2 CP Guojian Pharma Description and Business Overview
12.11.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 CP Guojian Pharma Biosimilar Drug Products Offered
12.11.5 CP Guojian Pharma Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Biosimilar Drug Industry Trends
13.2 Biosimilar Drug Market Drivers
13.3 Biosimilar Drug Market Challenges
13.4 Biosimilar Drug Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biosimilar Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Biosimilar Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Injection
Table 3. Major Manufacturers of Tablets
Table 4. Major Manufacturers of Other Types
Table 5. Global Biosimilar Drug Market Size Growth Rate by Application (2021-2027) & (K Dose)
Table 6. Global Biosimilar Drug Market Size by Region (K Dose) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Biosimilar Drug Sales by Regions (2016-2021) & (K Dose)
Table 8. Global Biosimilar Drug Sales Market Share by Regions (2016-2021)
Table 9. Global Biosimilar Drug Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Biosimilar Drug Sales Forecast by Region (2022-2027) & (K Dose)
Table 11. Global Biosimilar Drug Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Biosimilar Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Biosimilar Drug Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Biosimilar Drug Sales by Manufacturers (2016-2021) (K Dose)
Table 15. Global Biosimilar Drug Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Biosimilar Drug Manufacturers by Revenue (US$ Million) in 2020
Table 17. Biosimilar Drug Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Biosimilar Drug Revenue Share by Manufacturers (2016-2021)
Table 19. Global Biosimilar Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Biosimilar Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Drug as of 2020)
Table 21. Key Manufacturers Biosimilar Drug Price (2016-2021) (USD/Dose)
Table 22. Biosimilar Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Biosimilar Drug Product Type
Table 24. Date of International Manufacturers Enter into Biosimilar Drug Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Biosimilar Drug Sales by Type (2016-2021) (K Dose)
Table 27. Global Biosimilar Drug Sales Share by Type (2016-2021)
Table 28. Global Biosimilar Drug Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Biosimilar Drug Revenue Share by Type (2016-2021)
Table 30. Biosimilar Drug Average Selling Price (ASP) by Type (2016-2021) & (USD/Dose)
Table 31. Global Biosimilar Drug Sales Forecast by Type (2022-2027) & (K Dose)
Table 32. Global Biosimilar Drug Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Biosimilar Drug Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Biosimilar Drug Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Biosimilar Drug Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Dose)
Table 36. Global Biosimilar Drug Sales by Application (2016-2021) (K Dose)
Table 37. Global Biosimilar Drug Sales Share by Application (2016-2021)
Table 38. Global Biosimilar Drug Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Biosimilar Drug Revenue Share by Application (2016-2021)
Table 40. Biosimilar Drug Average Selling Price (ASP) by Application (2016-2021) & (USD/Dose)
Table 41. Global Biosimilar Drug Sales Forecast by Application (2022-2027) & (K Dose)
Table 42. Global Biosimilar Drug Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Biosimilar Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Biosimilar Drug Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Biosimilar Drug Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Dose)
Table 46. China Biosimilar Drug Sales (K Dose) of Key Companies (2016-2021)
Table 47. China Biosimilar Drug Sales Share by Company (2016-2021)
Table 48. China Biosimilar Drug Revenue (US$ Million) by Company (2016-2021)
Table 49. China Biosimilar Drug Revenue Share by Company (2016-2021)
Table 50. China Biosimilar Drug Sales (K Dose) by Type (2016-2021)
Table 51. China Biosimilar Drug Sales Share by Type (2016-2021)
Table 52. China Biosimilar Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Biosimilar Drug Price (USD/Dose) by Type (2016-2021)
Table 54. China Biosimilar Drug Sales (K Dose) by Type (2022-2027)
Table 55. China Biosimilar Drug Sales Share by Type (2022-2027)
Table 56. China Biosimilar Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Biosimilar Drug Revenue Share by Type (2022-2027)
Table 58. China Biosimilar Drug Price (USD/Dose) by Type (2022-2027)
Table 59. China Biosimilar Drug Sales (K Dose) by Application (2016-2021)
Table 60. China Biosimilar Drug Sales Share by Application (2016-2021)
Table 61. China Biosimilar Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Biosimilar Drug Price (USD/Dose) by Application (2016-2021)
Table 63. China Biosimilar Drug Sales (K Dose) by Application (2022-2027)
Table 64. China Biosimilar Drug Sales Share by Application (2022-2027)
Table 65. China Biosimilar Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Biosimilar Drug Revenue Share by Application (2022-2027)
Table 67. China Biosimilar Drug Price (USD/Dose) by Application (2022-2027)
Table 68. North America Biosimilar Drug Sales by Country (2016-2021) & (K Dose)
Table 69. North America Biosimilar Drug Sales Market Share by Country (2016-2021)
Table 70. North America Biosimilar Drug Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Biosimilar Drug Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Biosimilar Drug Sales by Region (2016-2021) & (K Dose)
Table 73. Asia Pacific Biosimilar Drug Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Biosimilar Drug Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Biosimilar Drug Revenue Market Share by Region (2016-2021)
Table 76. Europe Biosimilar Drug Sales by Country (2016-2021) & (K Dose)
Table 77. Europe Biosimilar Drug Sales Market Share by Country (2016-2021)
Table 78. Europe Biosimilar Drug Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Biosimilar Drug Revenue Market Share by Country (2016-2021)
Table 80. Latin America Biosimilar Drug Sales by Country (2016-2021) & (K Dose)
Table 81. Latin America Biosimilar Drug Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Biosimilar Drug Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Biosimilar Drug Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Biosimilar Drug Sales by Country (2016-2021) & (K Dose)
Table 85. Middle East and Africa Biosimilar Drug Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Biosimilar Drug Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Biosimilar Drug Revenue Market Share by Country (2016-2021)
Table 88. CP Guojian Pharma Corporation Information
Table 89. CP Guojian Pharma Description and Business Overview
Table 90. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 91. CP Guojian Pharma Biosimilar Drug Product
Table 92. CP Guojian Pharma Recent Development
Table 93. Biotech Pharma Corporation Information
Table 94. Biotech Pharma Description and Business Overview
Table 95. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 96. Biotech Pharma Product
Table 97. Biotech Pharma Recent Development
Table 98. Celgen Pharma Corporation Information
Table 99. Celgen Pharma Description and Business Overview
Table 100. Celgen Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 101. Celgen Pharma Product
Table 102. Celgen Pharma Recent Development
Table 103. Henlius Corporation Information
Table 104. Henlius Description and Business Overview
Table 105. Henlius Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 106. Henlius Product
Table 107. Henlius Recent Development
Table 108. Amgen Corporation Information
Table 109. Amgen Description and Business Overview
Table 110. Amgen Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 111. Amgen Product
Table 112. Amgen Recent Development
Table 113. Eli Lilly Corporation Information
Table 114. Eli Lilly Description and Business Overview
Table 115. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 116. Eli Lilly Product
Table 117. Eli Lilly Recent Development
Table 118. Sandoz Corporation Information
Table 119. Sandoz Description and Business Overview
Table 120. Sandoz Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 121. Sandoz Product
Table 122. Sandoz Recent Development
Table 123. Changchun High Tech Corporation Information
Table 124. Changchun High Tech Description and Business Overview
Table 125. Changchun High Tech Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 126. Changchun High Tech Product
Table 127. Changchun High Tech Recent Development
Table 128. Innovent Corporation Information
Table 129. Innovent Description and Business Overview
Table 130. Innovent Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 131. Innovent Product
Table 132. Innovent Recent Development
Table 133. Biosimilar Drug Market Trends
Table 134. Biosimilar Drug Market Drivers
Table 135. Biosimilar Drug Market Challenges
Table 136. Biosimilar Drug Market Restraints
Table 137. Biosimilar Drug Customers List
Table 138. Biosimilar Drug Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Biosimilar Drug Product Picture
Figure 2. Global Biosimilar Drug Sales Market Share by Type in 2020 & 2027
Figure 3. Injection Product Picture
Figure 4. Tablets Product Picture
Figure 5. Other Types Product Picture
Figure 6. Global Biosimilar Drug Sales Market Share by Application in 2020 & 2027
Figure 7. Ankylosing Spondylitis
Figure 8. Tumor
Figure 9. Rheumatoid Arthrtis
Figure 10. Cardiovascular
Figure 11. Other Application
Figure 12. Biosimilar Drug Report Years Considered
Figure 13. Global Biosimilar Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Biosimilar Drug Market Size 2016-2027 (US$ Million)
Figure 15. Global Biosimilar Drug Sales 2016-2027 (K Dose)
Figure 16. Global Biosimilar Drug Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global Biosimilar Drug Sales Market Share by Region (2016-2021)
Figure 18. Global Biosimilar Drug Sales Market Share by Region in 2020
Figure 19. Global Biosimilar Drug Revenue Market Share by Region (2016-2021)
Figure 20. Global Biosimilar Drug Revenue Market Share by Region in 2020
Figure 21. Global Biosimilar Drug Sales Share by Manufacturer in 2020
Figure 22. The Top 10 and 5 Players Market Share by Biosimilar Drug Revenue in 2020
Figure 23. Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global Biosimilar Drug Sales Market Share by Type (2016-2021)
Figure 25. Global Biosimilar Drug Sales Market Share by Type in 2020
Figure 26. Global Biosimilar Drug Revenue Market Share by Type (2016-2021)
Figure 27. Global Biosimilar Drug Revenue Market Share by Type in 2020
Figure 28. Global Biosimilar Drug Sales Market Share by Application (2016-2021)
Figure 29. Global Biosimilar Drug Sales Market Share by Application in 2020
Figure 30. Global Biosimilar Drug Revenue Market Share by Application (2016-2021)
Figure 31. Global Biosimilar Drug Revenue Market Share by Application in 2020
Figure 32. China Biosimilar Drug Sales Growth Rate 2016-2027 (K Dose)
Figure 33. China Biosimilar Drug Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. China Biosimilar Drug Market Share in Global Market 2016-2027
Figure 35. China 5 and 10 Largest Biosimilar Drug Players Market Share by Revenue in Biosimilar Drug in 2020
Figure 36. China Biosimilar Drug Revenue Share by Type (2016-2021)
Figure 37. China Biosimilar Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 38. China Biosimilar Drug Revenue Share by Application (2016-2021)
Figure 39. China Biosimilar Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America Biosimilar Drug Sales Growth Rate 2016-2021 (K Dose)
Figure 41. North America Biosimilar Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 42. North America Biosimilar Drug Sales Market Share by Country in 2020
Figure 43. North America Biosimilar Drug Revenue Market Share by Country in 2020
Figure 44. U.S. Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 45. U.S. Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Canada Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 47. Canada Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Europe Biosimilar Drug Sales Growth Rate 2016-2021 (K Dose)
Figure 49. Europe Biosimilar Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 50. Europe Biosimilar Drug Sales Market Share by Country in 2020
Figure 51. Europe Biosimilar Drug Revenue Market Share by Country in 2020
Figure 52. Germany Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 53. Germany Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. France Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 55. France Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. U.K. Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 57. U.K. Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Italy Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 59. Italy Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Russia Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 61. Russia Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Asia Pacific Biosimilar Drug Sales Growth Rate 2016-2021 (K Dose)
Figure 63. Asia Pacific Biosimilar Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 64. Asia Pacific Biosimilar Drug Sales Market Share by Region in 2020
Figure 65. Asia Pacific Biosimilar Drug Revenue Market Share by Region in 2020
Figure 66. China Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 67. China Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. Japan Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 69. Japan Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. South Korea Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 71. South Korea Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. India Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 73. India Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Australia Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 75. Australia Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. China Taiwan Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 77. China Taiwan Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Indonesia Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 79. Indonesia Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Thailand Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 81. Thailand Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Malaysia Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 83. Malaysia Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Latin America Biosimilar Drug Sales Growth Rate 2016-2021 (K Dose)
Figure 85. Latin America Biosimilar Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 86. Latin America Biosimilar Drug Sales Market Share by Country in 2020
Figure 87. Latin America Biosimilar Drug Revenue Market Share by Country in 2020
Figure 88. Mexico Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 89. Mexico Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Brazil Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 91. Brazil Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Argentina Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 93. Argentina Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Middle East and Africa Biosimilar Drug Sales Growth Rate 2016-2021 (K Dose)
Figure 95. Middle East and Africa Biosimilar Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 96. Middle East and Africa Biosimilar Drug Sales Market Share by Country in 2020
Figure 97. Middle East and Africa Biosimilar Drug Revenue Market Share by Country in 2020
Figure 98. Turkey Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 99. Turkey Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Saudi Arabia Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 101. Saudi Arabia Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. UAE Biosimilar Drug Sales Growth Rate (2016-2021) (K Dose)
Figure 103. UAE Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Biosimilar Drug Value Chain
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed
バイオシミラー薬品の世界市場 2020年 Market Overview The Biosimilar Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…- インターフェロンアルファ-2aバイオシミラーの世界市場 2020年 Market Overview The Interferon Alpha-2a Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- ハーセプチンバイオシミラーの世界市場 2020年 Market Overview The global Herceptin Biosimilar market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Herceptin Biosimilar mar…
- 多関節若年性特発性関節炎薬の世界市場 2020年 Market Overview The global Polyarticular Juvenile Idiopathic Arthritis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. …
- ベーチェット病治療薬の世界市場 2020年 Market Overview The global Behcet Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Behcet Disease Drug marke…